X-Linked Protoporphyria clinical trials at UCSF
2 in progress, 0 open to eligible people
Showing trials for
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
Sorry, accepting new patients by invitation only
This is an open-label, long-term extension study to investigate the safety, tolerability and efficacy of DISC-1459 in participants with EPP.
San Francisco, California and other locations
Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Sorry, in progress, not accepting new patients
To evaluate the long-term safety and tolerability of oral dersimelagon.
San Francisco, California and other locations